fda import alert glp-1 semaglutide tirzepatide green list Food and Drug Administration Launches “Green List” for Drug Important FDA update on GLP-1

We do not promise specific timelines or outcomes

Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)

Rush obesity medicine specialist Christopher Chapman, MD, explains

Extending this work, the research team posed as a secret shopper to purchase GLP-1RAs from previously surveyed websites and collected information about the prescription process and the extent of clinician involvement

The minimum effective dose of strength training, two short sessions a week across five movement patterns

This doctor-prescribed and supervised weight loss injection pen is US FDA-approved and works by...